H A R E S I G N

Primary care management consulting for GP practices and PCNs across England. IGPM Accredited Member.

Contact Info
Connect

LinkedIn

Primary care consulting for GP practices & PCNs across England. Get in touch →

Get In Touch

MHRA Class 4 Medicines Defect Notification: Meropenem 1000 mg powder and solvent for solution for infusion (B. Braun Melsungen AG)

Published
23 September 2026
Source
PSNC Dispensing & Supply News
Imported
23 Sep 2026

MHRA Class 4 Medicines Defect Notification: Meropenem 1000 mg powder and solvent for solution for infusion (B. Braun Melsungen AG) Drug alert number: EL(26)A/39 Date issued: 23 September 2026 B. Braun Melsungen AG has notified the MHRA that errors have been identified in the Patient Information Leaflet (PIL) included in some batches of Meropenem 1000 mg [...]

The post MHRA Class 4 Medicines Defect Notification: Meropenem 1000 mg powder and solvent for solution for infusion (B. Braun Melsungen AG) appeared first on Community Pharmacy England.

View Original Alert
Important: This alert is aggregated automatically for information only. Always refer to the original source and follow your practice's own clinical governance procedures.
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest

Back to Safety Alerts

Unlock your Practice Performance Overview

Register your practice for free to bring QOF, workforce, access, finance, contract and CQC data into a single live dashboard — benchmarked to national figures with an at-a-glance health score.